SYNBIO.INTEL
Terminal
Newsfeed
Platforms
Companies
Funding
Jobs
More ▾
⌘K Search
DNA
Ginkgo
+Platform
TWST
Twist
+Synthesis
ABSI
Absci
+AIDesign
CRSP
CRISPR Therapeutics
+Edit
BEAM
Beam
+BaseEdit
NTLA
Intellia
+InVivo
CRBU
Caribou
+CellTherapy
RXRX
Recursion
+AI
ILMN
Illumina
+Seq
EDIT
Editas
+Gene
FUND.YTD
2025
$17.3B.Raised
Funding Dashboard
Complete funding history for every synthetic biology company.
Total Tracked (2024–2026)
$7.0B
Largest Round
ArsenalBio $630M
Rounds Tracked
35
Avg Round Size
$201M
Company
↕
Round
↕
Amount
↕
Valuation
Lead Investors
Date
↓
Geography
↕
Cradle
Series B
$73M
Undisclosed
Index Ventures
Sep 10, 2024
Europe
EvolutionaryScale
Seed
$142M
~$500M
Nat Friedman, Daniel Gross, Lux Capital
Jun 25, 2024
USA
Aleph Farms
Series C
$105M
Undisclosed
L Catterton, DisruptAD
May 8, 2024
Israel
Tune Therapeutics
Series B
$175M
Undisclosed
ARCH Venture Partners, GV
Mar 12, 2024
USA
ArsenalBio
Series C
$630M
Undisclosed
Westlake Village BioPartners
Jan 18, 2024
USA
Volta Labs
Series B
$30M
Undisclosed
Khosla Ventures
Oct 18, 2023
USA
Arzeda
Series C
$32M
Undisclosed
Braavos Capital
Sep 20, 2023
USA
Spiber
Series F
$312M
Undisclosed
Carlyle Group
Jul 10, 2023
Japan
Chroma Medicine
Series B
$135M
Undisclosed
Atlas Venture, RA Capital
Jun 8, 2023
USA
Cemvita Factory
Series B
$20M
Undisclosed
United Airlines Ventures
May 15, 2023
USA
Cradle
Series A
$24M
Undisclosed
Index Ventures, Kindred Capital
Apr 5, 2023
Europe
bit.bio
Series C
$100M
Undisclosed
Foresite Capital, National Resilience
Mar 14, 2023
UK
Mammoth Biosciences
Series D
$195M
$3B+
Durable Capital Partners, Redmile Group
Sep 6, 2022
USA
Provivi
Series C
$45M
Undisclosed
DCVC Bio, Breakthrough Energy Ventures
Aug 22, 2022
USA
Solugen
Series D
$357M
$2B+
GIC, Baillie Gifford
Aug 15, 2022
USA
ArsenalBio
Series B
$220M
Undisclosed
a16z Bio, Kleiner Perkins
Jun 28, 2022
USA
Synthego
Series E
$200M
$2.7B
Emerson Collective
Jun 14, 2022
USA
Inari Agriculture
Series E
$124M
Undisclosed
Flagship Pioneering
Jun 1, 2022
USA
Generate Biomedicines
Series B
$370M
Undisclosed
T. Rowe Price, Fidelity
May 17, 2022
USA
Strand Therapeutics
Series B
$153M
Undisclosed
Flagship Pioneering
Apr 20, 2022
USA
Ecovative Design
Series D
$60M
Undisclosed
DCVC, Viking Global
Apr 12, 2022
USA
National Resilience
Series B
$625M
$4.6B
Flagship Pioneering, a16z Bio
Mar 22, 2022
USA
Cradle
Seed
$6M
Undisclosed
Kindred Capital
Mar 1, 2022
Europe
MycoWorks
Series C
$125M
Undisclosed
DCVC, SK Networks
Feb 8, 2022
USA
Benchling
Series F
$100M
$6.1B
Altimeter Capital
Jan 24, 2022
USA
Chroma Medicine
Series A
$125M
Undisclosed
Atlas Venture, Newpath Partners
Jan 11, 2022
USA
Nobell Foods
Series B
$75M
Undisclosed
Breakthrough Energy Ventures
Oct 19, 2021
USA
Bolt Threads
Series E
$253M
Undisclosed
Baillie Gifford, Fidelity
Sep 28, 2021
USA
Perfect Day
Series D
$350M
$1.5B+
Temasek, Canada Pension Plan
Sep 14, 2021
USA
Pivot Bio
Series D
$430M
$2B+
DCVC, Breakthrough Energy Ventures, Temasek
Aug 3, 2021
USA
Caribou Biosciences
IPO
$304M
$1B+ (initial)
J.P. Morgan, Cowen
Jul 23, 2021
USA
Absci Corporation
IPO
$198M
$3B (peak post-IPO)
Morgan Stanley, Jefferies
Jul 22, 2021
USA
Verve Therapeutics
Series B
$117M
Undisclosed
Andreessen Horowitz
May 12, 2021
USA
Recursion Pharmaceuticals
Series D
$239M
Undisclosed
Baillie Gifford, Casdin Capital
Mar 1, 2021
USA
Sana Biotechnology
IPO
$588M
$8.6B (peak post-IPO)
Goldman Sachs, J.P. Morgan
Feb 4, 2021
USA